Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinosarcoma of the prostate.

C F Lindboe1, K H Klem

  • 1Department of Pathology, Sørlandet Sykehus HF, Kristiansand, Norway. christian.fredrik.lindboe@sshf.no

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|March 8, 2006
PubMed
Summary

A rare case of advanced prostate cancer transformed into carcinosarcoma after treatment is presented. This aggressive transformation, featuring unusual cellular patterns, highlights a critical challenge in advanced cancer management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large cell neuroendocrine carcinoma of the ovary.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2007
Same author

Xanthoma of the urinary bladder.

International urology and nephrology·2005
Same author

Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.

Clinical neuropathology·2005
Same author

Adenoma of the esophagus with intracytoplasmic mucoid bodies.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2004
Same author

Brain weight: what does it mean?

Clinical neuropathology·2003
Same author

Determination of proliferation index in neoplasms using different Ki-67 equivalent antibodies.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica·2003

Area of Science:

  • Oncology
  • Pathology

Background:

  • Prostatic adenocarcinoma is a common malignancy in older men.
  • Metastatic prostate cancer often requires long-term hormonal therapy.

Observation:

  • A 66-year-old man with metastatic prostatic adenocarcinoma received a luteinizing hormone-releasing hormone analog for one year.
  • A subsequent biopsy revealed a significant transformation of the tumor.
  • The transformed tumor exhibited features of both carcinosarcoma and unusual differentiation.

Findings:

  • The carcinosarcoma demonstrated heterogeneous carcinomatous and sarcomatous components.
  • Noteworthy findings included a papillary growth pattern and liposarcomatous differentiation.
  • The patient's condition rapidly progressed post-diagnosis of carcinosarcoma, with death occurring 5 months later.

Implications:

  • This case underscores the potential for treatment-induced tumor dedifferentiation in advanced prostate cancer.
  • Understanding these rare transformations is crucial for developing novel therapeutic strategies.
  • Carcinosarcoma represents an aggressive subtype requiring distinct clinical and pathological considerations.

Related Experiment Videos